Wilmington, DE, United States of America

Gregory D Harris


Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1991-2003

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Gregory D. Harris: Innovator in Pharmaceutical Chemistry

Introduction

Gregory D. Harris is a notable inventor based in Wilmington, DE (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of 11 patents, showcasing his innovative approach to drug development and synthesis.

Latest Patents

Among his latest patents, one significant invention is the "Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitors." This invention focuses on the asymmetric synthesis of quinazolin-2-ones that serve as inhibitors of HIV reverse transcriptase. The synthesis process is achieved through the chiral ligand mediated addition of cyclopropylacetylide. Another important patent is the "Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate," which further demonstrates his expertise in creating complex pharmaceutical compounds.

Career Highlights

Throughout his career, Gregory D. Harris has worked with prominent companies in the pharmaceutical industry, including the DuPont Merck Pharmaceutical Company and Zeneca Limited. His work in these organizations has significantly contributed to advancements in drug development and synthesis techniques.

Collaborations

Gregory has collaborated with esteemed colleagues such as Marc Jerome Chapdelaine and Paul Francis Jackson, enhancing the impact of his research and innovations in the field.

Conclusion

Gregory D. Harris stands out as a significant figure in pharmaceutical chemistry, with a strong portfolio of patents that reflect his innovative spirit and dedication to improving healthcare through scientific advancements. His work continues to influence the development of effective treatments for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…